Norfolk, VA, October 20, 2020 — ReAlta Life Sciences, Inc., today announced the details of a formal ribbon-cutting ceremony at their...
Read MoreNorfolk, VA, July 28, 2020 — ReAlta Life Sciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has...
Read MoreNorfolk, VA, June 29, 2020 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive Officer,...
Read MoreNorfolk, VA, June 02, 2020 — ReAlta Life Sciences is pleased to have received a Commonwealth Research Commercialization Fund (CRCF) grant....
Read MoreNorfolk, VA, May 28, 2020 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming virtual BIO International Convention,...
Read MoreNorfolk, VA, April 21, 2020 — ReAlta Life Sciences, Inc., today announced that it has successfully closed an oversubscribed Series A2...
Read MoreNorfolk, VA, April 9, 2020 — ReAlta Life Sciences, Inc., a biotech company dedicated to harnessing the power of the immune...
Read MoreNorfolk, VA, March 10, 2020 — ReAlta Life Sciences, Inc., a biotechnology company dedicated to harnessing the power of the immune...
Read MoreNorfolk, VA, February 6, 2020 — ReAlta Life Sciences, Inc., today announced that U.S. Food and Drug Administration (FDA) has granted...
Read More